Why the study?
Does salbutamol have different bronchodilator and cardiovascular actions compared to isoprenaline and orciprenaline in guinea-pigs and dogs?
Does salbutamol have different bronchodilator and cardiovascular actions compared to isoprenaline and orciprenaline in guinea-pigs and dogs?
Salbutamol demonstrates selectivity for beta(2)-adrenoceptors over beta(1)-adrenoceptors compared to isoprenaline and orciprenaline in animal models.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for salbutamol's cardiac-sparing beta2 selectivity in animals; leaves open translation to human use.
Bronchodilator and cardiovascular actions of salbutamol and isoprenaline have been compared in guinea-pigs and dogs. Orciprenaline was also included in some experiments.2. All three drugs antagonized acetylcholine-induced increases in pulmonary resistance. In addition they increased heart rate and decreased arterial blood pressure.3. Compared with isoprenaline, salbutamol has relatively stronger actions on bronchial and vascular beta-adrenoceptors than on cardiac beta-adrenoceptors, on which its action is very weak. In contrast, orciprenaline has similar potencies on beta-adrenoceptors in these three tissues.4. The positive chronotropic potency of intravenously or orally administered salbutamol was increased in conscious dogs. These heart rate responses to salbutamol were probably mainly reflex in origin.5. Salbutamol and orciprenaline were both longer acting than isoprenaline.6. The results support the idea of two distinct groups of beta-adrenoceptors. Salbutamol differentiates between bronchial and vascular beta(2)-adrenoceptors on the one hand and cardiac beta(1)-adrenoceptors on the other. Isoprenaline and orciprenaline do not differentiate between beta(1)- and beta(2)-adrenoceptors.
No takes yet. Share an insight, caveat, or question.
Daly et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: